Some commentators say comparative trials of FDA-approved drugs are overburdened by current Common Rule regulations and that researchers should not be required to obtain explicit consent for participation in the most innocuous of these trials.
Patients with dementia need social supports and opportunities and acceptance of their disability in order to feel hopeful despite their functional decline.